Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQC
1226
DELISTED
Equity Commonwealth
EQC
| $219K | ﹤0.01% |
11,429
+500
| +5% | +$9.45K |
|
1227
Bloomin' Brands
BLMN
$996M
| $219K | ﹤0.01% |
7,787
-19,611
| -72% | -$477K |
|
|
PRO
1228
DELISTED
PROS Holdings
PRO
| $218K | ﹤0.01% |
5,629
-351
| -6% | -$12.6K |
|
1229
SouthState Bank Corp
SSB
$10.4B
| $217K | ﹤0.01% |
2,571
-2,373
| -48% | -$175K |
|
1230
Sotera Health
SHC
$5.58B
| $216K | ﹤0.01% |
12,841
-1,808
| -12% | -$25.6K |
|
1231
Varex Imaging
VREX
$780M
| $214K | ﹤0.01% |
+10,426
| New | +$199K |
|
|
SWI
1232
DELISTED
SolarWinds Corporation Common Stock
SWI
| $213K | ﹤0.01% |
17,069
-5,229
| -23% | -$56.2K |
|
1233
Teradyne
TER
$58.7B
| $213K | ﹤0.01% |
1,961
-2,147
| -52% | -$204K |
|
1234
Nutrien
NTR
$35.9B
| $212K | ﹤0.01% |
+3,772
| New | +$213K |
|
1235
Herc Holdings
HRI
$5.41B
| $212K | ﹤0.01% |
+1,423
| New | +$174K |
|
|
APLS
1236
DELISTED
Apellis Pharmaceuticals
APLS
| $210K | ﹤0.01% |
+3,513
| New | +$178K |
|
|
BDN
1237
Brandywine Realty Trust
BDN
$522M
| $210K | ﹤0.01% |
38,924
-6,679
| -15% | -$29.3K |
|
1238
Standard Motor Products
SMP
$863M
| $210K | ﹤0.01% |
+5,277
| New | +$188K |
|
1239
Freshpet
FRPT
$3.55B
| $208K | ﹤0.01% |
+2,402
| New | +$165K |
|
|
VRN
1240
DELISTED
Veren
VRN
| $208K | ﹤0.01% |
30,061
-52,257
| -63% | -$386K |
|
|
PDS
1241
Precision Drilling
PDS
$1.18B
| $207K | ﹤0.01% |
+3,819
| New | +$221K |
|
|
HOUS
1242
DELISTED
Anywhere Real Estate
HOUS
| $207K | ﹤0.01% |
+25,522
| New | +$145K |
|
|
NXH
1243
Neighborhood Intelligence Inc
NXH
$396M
| $207K | ﹤0.01% |
+8,205
| New | +$141K |
|
1244
NeoGenomics
NEO
$2.18B
| $207K | ﹤0.01% |
12,765
+1,690
| +15% | +$27.7K |
|
1245
The Bancorp
TBBK
$2.74B
| $206K | ﹤0.01% |
+5,342
| New | +$200K |
|
1246
Freshworks
FRSH
$3.39B
| $206K | ﹤0.01% |
8,758
-49,970
| -85% | -$989K |
|
1247
Primoris Services
PRIM
$4.15B
| $206K | ﹤0.01% |
+6,188
| New | +$193K |
|
1248
CBRE Group
CBRE
$44B
| $204K | ﹤0.01% |
2,194
-1,250
| -36% | -$97.2K |
|
|
THS
1249
DELISTED
Treehouse Foods
THS
| $204K | ﹤0.01% |
4,927
-2,139
| -30% | -$87.8K |
|
1250
Albany International
AIN
$1.68B
| $203K | ﹤0.01% |
+2,071
| New | +$181K |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.